The Pharmaceutical Journal: Number of adults prescribed ADHD medication rises by a quarter

Samantha Fletcher

Recent NHS data reveals that the number of adults prescribed ADHD medication in England has risen by 24% in the past year, with around 190,000 adults receiving prescriptions in 2024/25. Children also saw a 9.5% increase, with approximately 135,000 receiving ADHD medication. Over the past decade, overall prescriptions have more than tripled, growing from 107,000 in 2015/16 to over 326,000 in 2024/25. There has also been a notable shift in gender balance, with women now accounting for 38% of prescriptions compared to just 24% a decade ago, reflecting better recognition of ADHD in females. Experts suggest that the COVID-19 pandemic, the rise of telemedicine, and increased awareness have contributed to the surge, particularly among adults. ADHD UK’s Henry Shelford welcomed the growing diagnoses as a positive step in helping people get the support they need, while also emphasizing that many individuals remain undiagnosed and that systemic improvements are still necessary.

You can read the full article here:  https://pharmaceutical-journal.com/article/news/number-of-adults-prescribed-adhd-medication-rises-by-a-quarter